Authoratory™
 
This website is accredited by Health On the Net Foundation. Click to verify.
Bookmark and Share

8Hiroyuki Hanai

 

Summary for 2004 [at-glance overview of Hiroyuki Hanai work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Hiroyuki Hanai. According to available data, in 2004 Hiroyuki Hanai published at least 8 articles. This work was completed in collaboration with several authors including Takeuchi, Ken and Iida, Takayuki. Many other authors have collaborated with Hiroyuki Hanai as well. There is no information about the funding or the grants awarded to support this work.

Hiroyuki Hanai has rank 26 when compared to all other authors using the keyword Colitis, Ulcerative. Analysis of the article abstracts and the titles suggests that Hiroyuki Hanai professional interests are focused around "patients ulcerative colitis", "gastric cancer cell" and "cancer cell line". These might also be referred to as "ulcerative colitis", "gastric cancer" or "patients ulcerative". Statistical analysis shows that Hiroyuki Hanai's writing is likely to contains terms "patients", "colitis", "epha2", "ulcerative", "group" and "cancer".

Unfortunately, there is not enough information to establish Hiroyuki Hanai affiliation. Luckily, several email addresses are on file.

ENFRESRUAccurate information, makes sense to meInaccurate information, needs improvementmake correctionleave commentask question

Images [images we found on the Internet for Hiroyuki Hanai]

    loading...

    Do you know Hiroyuki Hanai who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to Hiroyuki Hanai]

Year 2004 Charts [Hiroyuki Hanai frequent coauthors and the most common unique vocabulary terms for the selected year]

  • Hiroyuki Hanai - Coauthors & Social Network in 2004Hiroyuki Hanai - Unique Vocabulary, Keywords and Interests in 2004

Historical Performance Charts [graphical overview of Hiroyuki Hanai publication and funding history for the range of years]

  • Hiroyuki Hanai - Publications and Funding History in 2004

Emails (3) [email addresses extracted from Hiroyuki Hanai affiliations]

hidden to prevent spam, click here to reveal

Other [context-specific ads]

Affiliations (6) [condensed summary of the Hiroyuki Hanai affiliations, the leading number and the color conveys importance]

  • 2Department of Medicine, Hamamatsu University, Hamamatsu, Japan.
    2First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.
    1Seirei Hamamatsu General Hospital, Hamamatsu 430-8558, Japan.
    1Department of Endoscopic and Photodynamic Medicine, Hamamatsu University, 1-20-1, Handayama, Hamamatsu 431-3192, Japan.
    1Department of Pharmacy, University of Tokyo Hospital, Faculty of Medicine, Tokyo, Japan.
    1Department of Endoscopic and Photodynamic Medicine, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.

Key Opinion Leader In [Hiroyuki Hanai is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

  • 26Colitis, Ulcerative

Keywords (32) [keywords assigned to Hiroyuki Hanai articles by PubMed, the leading number and the color conveys importance]

  • 8Humans | 7Male | 6Female | 5Middle Aged | 4Colitis, Ulcerative | 4Adult | 3Adolescent | 2Statistics, Nonparametric | 2Severity of Illness Index | 2Monocytes | 2Neutrophil Activation | 2Neutrophils | 2Aged | 1Gene Expression | 1C-Reactive Protein | 1Sensitivity and Specificity | 1Phytotherapy | 1DNA, Neoplasm | 1Genotype | 1Blood Component Removal | 1Immunotherapy | 1Tumor Cells, Cultured | 1Feces | 1Reverse Transcriptase Polymerase Chain Reaction | 1Magnetic Resonance Imaging | 1Mesalamine | 1Colorectal Neoplasms | 1Cohort Studies | 1Stomach Neoplasms | 1Liver Abscess | 1Chromatography, High Pressure Liquid | 1Antigens, CD

Hiroyuki Hanai Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Hiroyuki Hanai might be a good expert witness on these terms]

  • 14patients | 8colitis | 8epha2 | 8ulcerative | 8group | 8cancer | 8cell | 7gbf | 5ii | 5control | 5treatment | 5gma | 5rii | 5min | 5uc | 5remission | 5blood | 5significantly | 5activity | 5gastric | 5mkn45 | 4cells | 4therapy | 4efna1 | 4photofrin | 4correlation | 4microvessel | 4s-ri | 4neutrophils | 3peripheral | 3moderately | 3disease
  • 8ulcerative colitis | 5gastric cancer | 4patients ulcerative | 4s-ri rii | 3peripheral blood | 3control group | 3gbf group | 3moderately severe | 3epha2 efna1 | 3intestinal inflammation | 3patients active | 2stages ii | 2versus prednisolone | 2calprotectin intestinal | 2relationship fecal | 2neutrophils patients | 2receptors ii | 2soluble tnf-alpha | 2correlation serum | 2appeared effective | 2within min | 2apheresis versus | 2leukocytes adhere | 2cell death | 2active ulcerative | 2granulocyte monocyte | 2disease activity | 2cell viability | 2serum soluble | 2severe ulcerative | 2inflammation peripheral | 2activity patients
  • 4patients ulcerative colitis | 4gastric cancer cell | 4cancer cell line | 2severe ulcerative colitis | 2inflammation peripheral blood | 2granulocyte monocyte apheresis | 2prednisolone patients corticosteroid-dependent | 2calprotectin intestinal inflammation | 2neutrophils patients active | 2adsorptive granulocyte monocyte | 2intestinal inflammation peripheral | 2blood neutrophils patients | 2peripheral blood neutrophils | 2monocyte apheresis versus | 2patients active ulcerative | 2levels disease activity | 2patients corticosteroid-dependent moderately | 2relationship fecal calprotectin | 2activity patients ulcerative | 2disease activity patients | 2ii levels disease | 2receptors ii levels | 2correlation serum soluble | 2soluble tnf-alpha receptors | 2corticosteroid-dependent moderately severe | 2apheresis versus prednisolone | 2tnf-alpha receptors ii | 2serum soluble tnf-alpha | 2versus prednisolone patients | 2fecal calprotectin intestinal | 2active ulcerative colitis | 2moderately severe ulcerative

Reader's Comments (0) [comments posted by readers of Hiroyuki Hanai profile]

no comments yet

Funding (0) [selected NIH grants to Hiroyuki Hanai and the award amounts for recent years]

  • award information is not available

Hiroyuki Hanai Articles (8) [selected PubMed articles for the year 2004 with the links to a full text at PubMed]

Science Trivia (2) [Interactive math & science trivia questions]